Linked Data API

Show Search Form

Search Results

515951
registered interest false more like this
date less than 2016-04-26more like thismore than 2016-04-26
answering body
Department of Health remove filter
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading HIV Infection: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what further discussions his Department plans to hold with industry and other interested parties on the decision of NHS England to end the specialised commissioning process for HIV medicines used for Pre-Exposure Prophylaxis; what plans he has for the provision of such medicines before the end of the current pilot of early implementer sites over the next two years; and if he will make a statement. more like this
tabling member constituency Reigate remove filter
tabling member printed
Crispin Blunt more like this
uin 35694 more like this
answer
answer
is ministerial correction false more like this
date of answer remove filter
answer text <p>NHS England has agreed to carefully consider their position on commissioning pre-exposure prophylaxis (PrEP). Planning continues on the early implementer tests sites in the meantime. Irrespective of the commissioning arrangements for PrEP, decisions to fund will depend on full assessment of clinical and cost effectiveness and how it can be integrated with other HIV prevention efforts.</p> more like this
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2016-05-04T08:26:07.877Zmore like thismore than 2016-05-04T08:26:07.877Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
104
label Biography information for Crispin Blunt more like this